相关实验视频

Updated: May 10, 2026

Microdialysis of Ethanol During Operant Ethanol Self-administration and Ethanol Determination by Gas Chromatography

Microdialysis of Ethanol During Operant Ethanol Self-administration and Ethanol Determination by Gas Chromatography

Published on: September 5, 2012

乙醇锁疗法用于挽救受感染的道化血液透析导管:一个随机对照试验

Hari Prasad M K¹, Lalit K Pursnani¹, Himansu Sekhar Mahapatra¹

¹Department of Nephrology, Atal Bihari Vajpayee Institute of Medical Sciences & Dr Ram Manohar Lohia Hospital, New Delhi, India.

Clinical kidney journal

|March 4, 2026

概括

与抗生素结合的乙醇锁治疗 (ELT) 改善了血液中感染的血液透析患者的导管存活率. 这种辅助疗法减少了感染的复发,并提高了早期导管救援率.

科学领域:

腎臟病學 (nephrology) 是一種醫學.
传染性疾病传染性疾病
医疗器械医疗器械

背景情况:

道导管相关的血流感染 (CRBSI) 是血液透析 (HD) 的重要并发症.
导管上的生物膜形成使管理变得复杂,需要有效的治疗策略.
乙醇锁疗法 (ELT) 显示出作为抗生素辅助剂的承诺,用于导管救援.

研究的目的:

评估70%乙醇锁疗法 (ELT) 作为静脉注射抗生素补充剂的疗效,用于治疗HD患者的CRBSI.
为了比较接受ELT加抗生素和仅接受抗生素的患者之间的导管救援率,复发率和存活率.

主要方法:

进行了一项单中心,开放标签,随机对照试验.
成年患有怀疑或确诊的CRBSI的HD患者被随机分为两组:ELT加抗生素或仅服用抗生素.
主要结局是7天的导管救援;次要结局包括60天的复发和导管存活率.

主要成果:

与对照组相比,ELT组 (78.6%) 的早期导管救援显著高于对照组 (57.1%;P=.035).
在第60天的复发率与ELT (20.5%) 相比,对照组 (53.7%;P=.002) 的复发率明显较低.
到第7天发烧的缓解率在ELT组 (64.3%) 与对照组 (35.7%;P=.009) 相比也明显高.

结论:

辅助乙醇锁治疗 (ELT) 显著改善了早期的导管救援,并减少了道导管感染的复发.
在血液透析患者中,ELT是抗生素协议的安全有效补充,用于管理CRBSI.
这些发现支持将ELT整合到道导管相关感染的救援协议中.

关键词:

与导管相关的感染.乙醇锁可以锁定.道导管是通过道导管进行的.

更多相关视频

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

相关概念视频

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

Hemodialysis II: Procedure and Complications

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...